| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium berghei | 54 | 2022 | 168 | 10.060 |
Why?
|
| Malaria | 75 | 2023 | 1232 | 8.430 |
Why?
|
| Plasmodium | 39 | 2023 | 248 | 8.200 |
Why?
|
| Sporozoites | 31 | 2020 | 82 | 4.540 |
Why?
|
| Host-Parasite Interactions | 24 | 2022 | 294 | 4.510 |
Why?
|
| Hepatocytes | 38 | 2022 | 1209 | 4.440 |
Why?
|
| Parasites | 8 | 2023 | 161 | 3.530 |
Why?
|
| Protozoan Proteins | 20 | 2023 | 827 | 2.800 |
Why?
|
| Antimalarials | 30 | 2022 | 903 | 2.680 |
Why?
|
| Liver | 46 | 2023 | 7470 | 2.490 |
Why?
|
| Plasmodium falciparum | 27 | 2022 | 1726 | 1.970 |
Why?
|
| Malaria, Cerebral | 6 | 2023 | 135 | 1.460 |
Why?
|
| Vacuoles | 7 | 2017 | 230 | 1.450 |
Why?
|
| Phosphotransferases | 3 | 2023 | 309 | 1.060 |
Why?
|
| Antigens, Protozoan | 8 | 2015 | 322 | 0.950 |
Why?
|
| Erythrocytes | 17 | 2023 | 2452 | 0.930 |
Why?
|
| Plasmodium yoelii | 9 | 2010 | 39 | 0.830 |
Why?
|
| Toxoplasma | 3 | 2018 | 150 | 0.820 |
Why?
|
| Mice, Inbred C57BL | 35 | 2023 | 21821 | 0.800 |
Why?
|
| Animals | 104 | 2023 | 168561 | 0.750 |
Why?
|
| Membrane Proteins | 6 | 2020 | 7873 | 0.710 |
Why?
|
| Hep G2 Cells | 7 | 2017 | 392 | 0.670 |
Why?
|
| Life Cycle Stages | 10 | 2022 | 160 | 0.660 |
Why?
|
| Erythropoiesis | 1 | 2023 | 705 | 0.660 |
Why?
|
| Mice | 65 | 2023 | 81045 | 0.660 |
Why?
|
| Malaria, Falciparum | 6 | 2018 | 1071 | 0.640 |
Why?
|
| Mice, Inbred BALB C | 18 | 2020 | 6382 | 0.630 |
Why?
|
| Amino Acids | 1 | 2023 | 1727 | 0.570 |
Why?
|
| Autophagy | 3 | 2020 | 1301 | 0.530 |
Why?
|
| Heme Oxygenase-1 | 3 | 2011 | 381 | 0.530 |
Why?
|
| Parasitic Diseases | 1 | 2015 | 75 | 0.510 |
Why?
|
| Phosphatidylcholines | 2 | 2023 | 411 | 0.490 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2015 | 122 | 0.490 |
Why?
|
| Host-Pathogen Interactions | 4 | 2017 | 1477 | 0.480 |
Why?
|
| Unfolded Protein Response | 1 | 2015 | 230 | 0.450 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2017 | 1086 | 0.440 |
Why?
|
| Naphthyridines | 1 | 2013 | 118 | 0.440 |
Why?
|
| Anopheles | 6 | 2018 | 197 | 0.400 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 405 | 0.400 |
Why?
|
| Carbon Monoxide | 3 | 2011 | 531 | 0.390 |
Why?
|
| Superinfection | 1 | 2011 | 65 | 0.390 |
Why?
|
| Flow Cytometry | 7 | 2013 | 5975 | 0.380 |
Why?
|
| Interferon Type I | 1 | 2013 | 542 | 0.360 |
Why?
|
| Acute Lung Injury | 2 | 2011 | 378 | 0.360 |
Why?
|
| Cell Line | 13 | 2020 | 15994 | 0.360 |
Why?
|
| Mitosis | 1 | 2014 | 1208 | 0.340 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2008 | 81 | 0.340 |
Why?
|
| Iron | 2 | 2022 | 1773 | 0.330 |
Why?
|
| Genistein | 1 | 2008 | 84 | 0.320 |
Why?
|
| Amino Acyl-tRNA Synthetases | 2 | 2022 | 91 | 0.320 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2009 | 708 | 0.320 |
Why?
|
| Microscopy | 2 | 2013 | 903 | 0.320 |
Why?
|
| Parasitemia | 5 | 2017 | 174 | 0.320 |
Why?
|
| Liver Diseases | 3 | 2017 | 1252 | 0.310 |
Why?
|
| Cell Movement | 2 | 2013 | 5212 | 0.300 |
Why?
|
| Immunity, Innate | 5 | 2015 | 2956 | 0.300 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2009 | 311 | 0.300 |
Why?
|
| Locomotion | 1 | 2009 | 378 | 0.300 |
Why?
|
| Azepines | 1 | 2009 | 336 | 0.290 |
Why?
|
| Bacterial Infections | 1 | 2015 | 1389 | 0.290 |
Why?
|
| Alanine | 1 | 2009 | 572 | 0.290 |
Why?
|
| Protein Multimerization | 1 | 2012 | 971 | 0.280 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 54 | 0.280 |
Why?
|
| Green Fluorescent Proteins | 9 | 2015 | 2088 | 0.270 |
Why?
|
| Actins | 2 | 2012 | 2120 | 0.270 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 9410 | 0.270 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 18006 | 0.270 |
Why?
|
| Heme | 1 | 2007 | 307 | 0.260 |
Why?
|
| Malaria Vaccines | 4 | 2008 | 158 | 0.260 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 790 | 0.250 |
Why?
|
| GTP Phosphohydrolases | 2 | 2022 | 508 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 12071 | 0.240 |
Why?
|
| Protein Kinases | 2 | 2014 | 1638 | 0.240 |
Why?
|
| Hemeproteins | 3 | 2013 | 62 | 0.240 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1227 | 0.230 |
Why?
|
| Imines | 2 | 2013 | 33 | 0.230 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1899 | 0.220 |
Why?
|
| Luciferases | 3 | 2014 | 733 | 0.220 |
Why?
|
| eIF-2 Kinase | 1 | 2023 | 150 | 0.210 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2003 | 270 | 0.210 |
Why?
|
| Mammals | 3 | 2023 | 1135 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2023 | 341 | 0.190 |
Why?
|
| Transformation, Genetic | 1 | 2001 | 192 | 0.190 |
Why?
|
| Oocysts | 2 | 2018 | 20 | 0.190 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 3504 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1599 | 0.190 |
Why?
|
| Humans | 69 | 2023 | 742088 | 0.190 |
Why?
|
| Quinolones | 2 | 2013 | 366 | 0.180 |
Why?
|
| Drug Resistance | 6 | 2015 | 1608 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2003 | 578 | 0.170 |
Why?
|
| Microarray Analysis | 2 | 2013 | 766 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2020 | 3139 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4751 | 0.170 |
Why?
|
| Virulence | 2 | 2017 | 1328 | 0.170 |
Why?
|
| Cells, Cultured | 10 | 2020 | 19223 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3502 | 0.170 |
Why?
|
| Plasmodium vivax | 3 | 2015 | 207 | 0.160 |
Why?
|
| Trypanosoma | 1 | 2018 | 16 | 0.160 |
Why?
|
| Models, Molecular | 6 | 2017 | 5454 | 0.160 |
Why?
|
| Quinazolinones | 2 | 2022 | 221 | 0.160 |
Why?
|
| Protein Binding | 3 | 2020 | 9387 | 0.160 |
Why?
|
| Transfection | 3 | 2006 | 5892 | 0.160 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 2885 | 0.150 |
Why?
|
| Digestive System | 1 | 2018 | 251 | 0.150 |
Why?
|
| Endocytosis | 1 | 2022 | 983 | 0.150 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2015 | 39 | 0.150 |
Why?
|
| Signal Transduction | 5 | 2015 | 23387 | 0.150 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 152 | 0.150 |
Why?
|
| Coculture Techniques | 3 | 2016 | 1341 | 0.150 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2017 | 27 | 0.150 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2017 | 89 | 0.150 |
Why?
|
| Primaquine | 2 | 2019 | 28 | 0.150 |
Why?
|
| Sickle Cell Trait | 1 | 2017 | 81 | 0.150 |
Why?
|
| Quinolines | 2 | 2013 | 719 | 0.150 |
Why?
|
| Luteolin | 1 | 2016 | 12 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2023 | 900 | 0.140 |
Why?
|
| Palmitic Acids | 1 | 2016 | 54 | 0.140 |
Why?
|
| Culicidae | 3 | 2011 | 104 | 0.140 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 561 | 0.140 |
Why?
|
| Male | 21 | 2020 | 349538 | 0.140 |
Why?
|
| Plasmodium chabaudi | 2 | 2010 | 22 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2017 | 272 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 2505 | 0.140 |
Why?
|
| Ethanolamines | 1 | 2016 | 158 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2020 | 4013 | 0.140 |
Why?
|
| Structure-Activity Relationship | 7 | 2015 | 3133 | 0.130 |
Why?
|
| Genome, Human | 1 | 2008 | 4420 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 302 | 0.120 |
Why?
|
| Protein Transport | 1 | 2020 | 1988 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 1150 | 0.120 |
Why?
|
| Fatty Acids | 2 | 2022 | 1806 | 0.120 |
Why?
|
| Exocytosis | 2 | 2008 | 353 | 0.120 |
Why?
|
| Parasitic Sensitivity Tests | 4 | 2019 | 83 | 0.120 |
Why?
|
| Flavones | 1 | 2013 | 66 | 0.120 |
Why?
|
| Seaweed | 1 | 2013 | 28 | 0.120 |
Why?
|
| Genome, Protozoan | 1 | 2014 | 142 | 0.110 |
Why?
|
| Parasitology | 1 | 2013 | 29 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4200 | 0.110 |
Why?
|
| Oligonucleotides | 2 | 2013 | 572 | 0.110 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 123 | 0.110 |
Why?
|
| Cell Line, Tumor | 11 | 2016 | 16665 | 0.110 |
Why?
|
| Pyrimethamine | 4 | 2011 | 98 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 608 | 0.110 |
Why?
|
| Mice, Inbred DBA | 2 | 2011 | 642 | 0.110 |
Why?
|
| Metformin | 1 | 2019 | 829 | 0.110 |
Why?
|
| Artemisinins | 2 | 2011 | 222 | 0.110 |
Why?
|
| Thiogalactosides | 1 | 2011 | 7 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2019 | 1372 | 0.110 |
Why?
|
| Genes, Protozoan | 3 | 2022 | 163 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2015 | 513 | 0.100 |
Why?
|
| Skin | 2 | 2008 | 4353 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2183 | 0.100 |
Why?
|
| Organisms, Genetically Modified | 1 | 2012 | 64 | 0.100 |
Why?
|
| Plasmodium malariae | 1 | 2011 | 14 | 0.100 |
Why?
|
| Piperidines | 2 | 2022 | 1602 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2023 | 8436 | 0.100 |
Why?
|
| Indole Alkaloids | 1 | 2011 | 24 | 0.100 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
| Gelsolin | 1 | 2012 | 190 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 546 | 0.100 |
Why?
|
| Toxoplasmosis | 1 | 2011 | 91 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 375 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 459 | 0.090 |
Why?
|
| Cell Shape | 1 | 2011 | 375 | 0.090 |
Why?
|
| Mefloquine | 3 | 2019 | 55 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11470 | 0.090 |
Why?
|
| Chloroquine | 4 | 2013 | 280 | 0.090 |
Why?
|
| Arginase | 1 | 2010 | 79 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2013 | 469 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2015 | 14554 | 0.090 |
Why?
|
| Glucose | 3 | 2017 | 4391 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2077 | 0.090 |
Why?
|
| Salivary Glands | 1 | 2011 | 228 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 712 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2018 | 1606 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 941 | 0.090 |
Why?
|
| Lung | 3 | 2022 | 9826 | 0.090 |
Why?
|
| Antioxidants | 1 | 2017 | 1659 | 0.090 |
Why?
|
| Anions | 1 | 2009 | 133 | 0.090 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2011 | 440 | 0.090 |
Why?
|
| Pneumocystis carinii | 1 | 2009 | 74 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 362 | 0.080 |
Why?
|
| Mast Cells | 1 | 2016 | 1544 | 0.080 |
Why?
|
| Proteomics | 2 | 2015 | 3618 | 0.080 |
Why?
|
| Quinazolines | 1 | 2015 | 1355 | 0.080 |
Why?
|
| Macrophages | 2 | 2017 | 5655 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2015 | 1547 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2015 | 1372 | 0.080 |
Why?
|
| Primates | 1 | 2011 | 543 | 0.080 |
Why?
|
| Tubulin | 1 | 2012 | 695 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 226 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 665 | 0.080 |
Why?
|
| Gold | 1 | 2011 | 483 | 0.080 |
Why?
|
| Kinetics | 2 | 2013 | 6474 | 0.080 |
Why?
|
| Animals, Genetically Modified | 4 | 2017 | 1546 | 0.070 |
Why?
|
| Pulmonary Circulation | 1 | 2010 | 739 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 590 | 0.070 |
Why?
|
| Mitochondria | 2 | 2018 | 3520 | 0.070 |
Why?
|
| DNA Primers | 2 | 2009 | 2892 | 0.070 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2006 | 62 | 0.070 |
Why?
|
| RNA, Protozoan | 1 | 2006 | 43 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 944 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2915 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3862 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3800 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2017 | 3081 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3278 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1887 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2007 | 258 | 0.070 |
Why?
|
| Drug Design | 2 | 2015 | 1078 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2896 | 0.070 |
Why?
|
| Globins | 1 | 2007 | 415 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2013 | 5180 | 0.070 |
Why?
|
| Thymidylate Synthase | 2 | 2006 | 75 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2013 | 2211 | 0.070 |
Why?
|
| Dendritic Cells | 3 | 2007 | 2723 | 0.070 |
Why?
|
| Chimera | 1 | 2007 | 485 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2014 | 2968 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2013 | 3744 | 0.070 |
Why?
|
| Blood Group Antigens | 1 | 2007 | 179 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1670 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2008 | 1538 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2010 | 663 | 0.060 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 2006 | 143 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2723 | 0.060 |
Why?
|
| Molecular Structure | 3 | 2015 | 1907 | 0.060 |
Why?
|
| Rats | 3 | 2017 | 24265 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9735 | 0.060 |
Why?
|
| Cell Survival | 1 | 2014 | 5872 | 0.060 |
Why?
|
| Ion Channels | 1 | 2009 | 1056 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
| Phagocytosis | 2 | 2007 | 1538 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1470 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2004 | 853 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1728 | 0.060 |
Why?
|
| Imidazoles | 1 | 2009 | 1205 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2023 | 73 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1989 | 0.060 |
Why?
|
| Biological Transport | 1 | 2007 | 2119 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2006 | 2049 | 0.050 |
Why?
|
| Leukocytes | 1 | 2011 | 2039 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2007 | 2003 | 0.050 |
Why?
|
| Immunization | 1 | 2007 | 1255 | 0.050 |
Why?
|
| Dyspnea | 1 | 2010 | 1298 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 81 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3258 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2007 | 2715 | 0.050 |
Why?
|
| Movement | 2 | 2008 | 1470 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 969 | 0.050 |
Why?
|
| Genotype | 1 | 2016 | 12946 | 0.050 |
Why?
|
| Apoptosis | 3 | 2005 | 9715 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1788 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 1107 | 0.050 |
Why?
|
| Luminescence | 2 | 2011 | 137 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2011 | 1902 | 0.050 |
Why?
|
| Plasmids | 2 | 2006 | 2305 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11363 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2015 | 5100 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2022 | 313 | 0.040 |
Why?
|
| Phospholipids | 1 | 2023 | 781 | 0.040 |
Why?
|
| Base Sequence | 2 | 2009 | 12797 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4742 | 0.040 |
Why?
|
| Myosins | 1 | 2001 | 409 | 0.040 |
Why?
|
| Subtilisin | 1 | 2018 | 12 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2008 | 4211 | 0.040 |
Why?
|
| Lipase | 1 | 2020 | 315 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9639 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 10943 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2019 | 229 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 880 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 686 | 0.040 |
Why?
|
| Trypanosomiasis, African | 1 | 2016 | 28 | 0.040 |
Why?
|
| Vaccination | 2 | 2006 | 3256 | 0.040 |
Why?
|
| Neurons | 1 | 2016 | 9325 | 0.040 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2016 | 43 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 5522 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1827 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2008 | 3294 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2016 | 287 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12164 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2016 | 424 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 15530 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2017 | 477 | 0.030 |
Why?
|
| Chagas Disease | 1 | 2016 | 166 | 0.030 |
Why?
|
| Gene Expression | 1 | 2008 | 7790 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 198 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2015 | 107 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2011 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 2217 | 0.030 |
Why?
|
| Female | 8 | 2017 | 379592 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13256 | 0.030 |
Why?
|
| Vaccines, Attenuated | 2 | 2005 | 341 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
| Electron Transport Complex III | 1 | 2013 | 31 | 0.030 |
Why?
|
| Time Factors | 3 | 2015 | 40054 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2013 | 253 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2013 | 175 | 0.030 |
Why?
|
| Amides | 1 | 2016 | 458 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 298 | 0.030 |
Why?
|
| Oxygen | 2 | 2016 | 4169 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2001 | 2751 | 0.030 |
Why?
|
| Bioethics | 1 | 2014 | 115 | 0.030 |
Why?
|
| Histones | 1 | 2023 | 2597 | 0.030 |
Why?
|
| Decoquinate | 1 | 2012 | 3 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 625 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6313 | 0.030 |
Why?
|
| Crystallization | 1 | 2013 | 525 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1526 | 0.030 |
Why?
|
| Atovaquone | 1 | 2012 | 58 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2011 | 2257 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 2011 | 81 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 449 | 0.030 |
Why?
|
| Cytokines | 1 | 2007 | 7317 | 0.030 |
Why?
|
| Insect Vectors | 1 | 2012 | 134 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2917 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2011 | 174 | 0.020 |
Why?
|
| Quinine | 1 | 2011 | 54 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 18112 | 0.020 |
Why?
|
| Hemin | 1 | 2011 | 49 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2011 | 248 | 0.020 |
Why?
|
| Animal Experimentation | 1 | 2011 | 45 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2011 | 163 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2011 | 190 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3701 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1158 | 0.020 |
Why?
|
| Hepatitis B | 1 | 2015 | 695 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3639 | 0.020 |
Why?
|
| Vero Cells | 1 | 2011 | 485 | 0.020 |
Why?
|
| Nitrobenzoates | 1 | 2009 | 17 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.020 |
Why?
|
| Adipocytes | 1 | 2016 | 1182 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2009 | 517 | 0.020 |
Why?
|
| Chlorine | 1 | 2009 | 50 | 0.020 |
Why?
|
| Clomiphene | 1 | 2009 | 72 | 0.020 |
Why?
|
| Drug Stability | 1 | 2009 | 290 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6483 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 404 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 3001 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6608 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 13814 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 721 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 17400 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2022 | 7721 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2011 | 860 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 16331 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2011 | 558 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 563 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2015 | 1348 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2890 | 0.020 |
Why?
|
| Binding Sites | 1 | 2017 | 6115 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2011 | 582 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 643 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1583 | 0.020 |
Why?
|
| Uracil | 1 | 2008 | 164 | 0.020 |
Why?
|
| Cysteine | 1 | 2011 | 873 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 3293 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3199 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14720 | 0.020 |
Why?
|
| Brain | 2 | 2010 | 26343 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 2014 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2015 | 1582 | 0.020 |
Why?
|
| Models, Biological | 1 | 2002 | 9581 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2015 | 4143 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 4249 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2005 | 803 | 0.020 |
Why?
|
| Proteins | 2 | 2015 | 6096 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2009 | 980 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2906 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 251 | 0.020 |
Why?
|
| Disease Transmission, Infectious | 1 | 2009 | 546 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2010 | 1015 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2005 | 221 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1915 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4438 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2011 | 1057 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 759 | 0.010 |
Why?
|
| Zebrafish | 1 | 2014 | 2990 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2005 | 340 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 928 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 176 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 40955 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3518 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 121 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 2867 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2015 | 5019 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 547 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10248 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2003 | 579 | 0.010 |
Why?
|
| Longevity | 1 | 2008 | 1069 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1224 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 2015 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 936 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2005 | 952 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 926 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2699 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 849 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2002 | 1251 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 1200 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Indoles | 1 | 2005 | 1834 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 1073 | 0.010 |
Why?
|
| DNA | 1 | 2011 | 7289 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 1423 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 3420 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3507 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5867 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2003 | 2257 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 62966 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13029 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3770 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5519 | 0.010 |
Why?
|